Pharmadrug Inc.
PHRX
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 98.40% | 97.48% | 97.10% | 93.96% | -1,037.81% |
| Total Depreciation and Amortization | -23.40% | -4.50% | 26.57% | 90.16% | 761.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -100.00% |
| Total Other Non-Cash Items | -99.14% | -98.34% | -97.75% | -97.61% | 334.12% |
| Change in Net Operating Assets | 84.34% | 94.90% | -284.07% | -201.74% | -192.31% |
| Cash from Operations | 90.93% | 92.20% | 80.05% | -12.43% | -139.13% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4,200.00% | -248.28% | -125.29% | -104.58% | -100.08% |
| Cash from Investing | -101.58% | -101.56% | -101.49% | -101.17% | 111.24% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -- | -100.00% | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 270.65% | -64.97% | -63.98% | -60.65% | -118.74% |
| Cash from Financing | -101.57% | -100.75% | -100.64% | 41.02% | 30.56% |
| Foreign Exchange rate Adjustments | -383.33% | -230.77% | -200.00% | -177.27% | -85.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -248.33% | -186.74% | -172.99% | -181.16% | -118.97% |